Home › Mga Sakit sa Baga › Nevada
Pag-aaral pangklinika para sa Mga Sakit sa Baga sa Nevada
6 pag-aaral para sa Mga Sakit sa Baga ang naghahanap ng mga kalahok sa mga site sa Nevada.
Mga Lungsod sa Nevada
Opisyal na teksto ng pag-aaral (English)
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Las Vegas Clinical Trials, North Las Vegas
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06679140A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Henderson Clinical Trials, Henderson
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06977581A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Comprehensive Cancer Centers of Nevada, Las Vegas
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Renown Regional Medical Center, Reno
Nagre-recruitPhase 3
Edad 40 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07284602A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.
- Comprehensive Cancer Centers of Nevada - Central Valley - Twain, Las Vegas
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 1, 2026 · NCT05967689A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers
- PPD - Las Vegas Research Unit, Las Vegas
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT07745907Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.